
Triple agonist peptide for metabolic research studies
Retatrutide is a novel triple agonist peptide that activates GIP, GLP-1, and glucagon receptors. Research indicates potential applications in metabolic studies and energy expenditure research.
For laboratory research purposes only. Not for human consumption.